Efficacy and Safety of Intravenous Secukinumab in Noninfectious Uveitis Requiring Steroid-Sparing Immunosuppressive Therapy

Effects of AIN457, a Fully Human Antibody to Interleukin-17A, on Psoriasis, Rheumatoid Arthritis, and Uveitis

Wolfgang Hueber, Dhavalkumar D. Patel, Thaddeus P. Dryja et al. · Science Translational Medicine · 2010 · 858 citations

TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STAT1

Ahjoku Amadi‐Obi, Cheng‐Rong Yu, Xuebin Liu et al. · Nature Medicine · 2007 · 842 citations

Inflammation, Cytokine, Allergy +9

Incidence and prevalence of uveitis in Northern California The Northern California Epidemiology of Uveitis Study

David C. Gritz · Ophthalmology · 2004 · 838 citations

Northern California Epidemiology, Clinical Epidemiology, Public Health +3

Degree, duration, and causes of visual loss in uveitis

Omar M. Durrani · British Journal of Ophthalmology · 2004 · 510 citations · Full text

Secukinumab in the Treatment of Noninfectious Uveitis: Results of Three Randomized, Controlled Clinical Trials

Andrew D. Dick, İlknur Tuğal-Tutkun, Stephen C. Foster et al. · Ophthalmology · 2013 · 350 citations

Ocular Disease, Noninfectious Uveitis, Ophthalmology +7